To label or not to label? The paradox of small-molecule probes in biological characterization

1 Introduction

The “observer effect” in cell imaging is not a metaphor; it is a physical and chemical consequence of measurement (Tu et al., 2017; Shaked et al., 2023). Whenever a synthetic probe is introduced into a living system, the measured system acquires new reaction pathways—binding, sequestration, catalysis, and photochemistry—that can alter state occupancies and fluxes (Lavis and Raines, 2008; 2014; Lavis, 2017). In fluorescence microscopy, this observer effect is further amplified because the probe must (i) be present at sufficient concentration, (ii) reside in the correct subcellular compartment, and (iii) be driven into excited states by light. The net result is that measurement can alter the distribution of analytes, the structure–function relationships of organelles, and the redox balance of cells—transforming the observer into an inadvertent participant.

Label-free optical imaging emerged, in part, as a scientific response to this paradox (Ntziachristos, 2010). A central claim of this approach is that if contrast originates from intrinsic properties—refractive index, scattering, absorption, molecular vibrations, or autofluorescence—the measurement is inherently less perturbative than extrinsic labeling, particularly for long-term or in vivo observations. A landmark Nature Photonics review explicitly notes that exogenous dyes and stains can affect inherent metabolic processes and that label-free methods are attractive precisely because they circumvent this confounding perturbation while providing contrast tied to microenvironmental properties such as chemical composition and pH (Tu et al., 2017; Shaked et al., 2023). However, label-free imaging introduces a different tension: intrinsic signals are often spectrally congested, overlapping, and mechanistically ambiguous, motivating the continued use of exogenous labels as validation tools and ground-truth references (Szulczewski et al., 2024).

This reveals a fundamental dialectic between (a) the high sensitivity and molecular specificity enabled by synthetic probes and (b) the high physiological fidelity enabled by intrinsic contrast. The remainder of this review dissects the mechanisms that generate this conflict and evaluates the strategies being developed to navigate it. Section 2 characterizes native fluorescence as a minimal back-action benchmark. Sections 3–5 analyze specific perturbation mechanisms: Ca²⁺ buffering, organelle interference and dark toxicity, and phototoxicity. Section 6 assesses targeting strategies and their failure modes. Sections 7–8 evaluate quantitative imaging modalities and propose design principles for minimally perturbative probes.

2 Native fluorescence as a “minimal back-action” benchmark

The appeal of native fluorescence as a reference condition is not merely operational convenience, it is a conceptual argument about what constitutes a legitimate measurement in a living system. If the act of labeling introduces new chemical equilibria, alters subcellular distributions, or adds photochemical pathways absent in the unperturbed cell, then the measured signal is, by definition, a property of the probe-cell composite rather than of the cell alone. Endogenous fluorophores, aromatic amino acids, kynurenine metabolites, and redox cofactors such as NAD(P)H and flavins, circumvent this problem not because they are ideal reporters, but because they are constitutive components of cellular biochemistry whose optical properties are a consequence of function rather than a precondition for it (Blacker and Duchen, 2016; Kolenc and Quinn, 2019). This distinction matters: it places native fluorescence in an epistemically privileged position as a lower bound on perturbation, against which every exogenous labeling strategy must be benchmarked. However, accepting this benchmark uncritically would be equally misleading. Native fluorophores are spectrally congested, mechanistically ambiguous, and concentration-dependent in ways that resist straightforward quantitative interpretation (Molnar and Miskolci, 2024; Szulczewski et al., 2024). The sections that follow therefore treat label-free imaging neither as a gold standard nor as a curiosity, but as the sharpest available diagnostic for asking how much a probe has changed the system it claims to report. In Figure 1, examples of endogenous fluorophores are presented along with their biochemical relationship and optical properties.

2.1 Endogenous fluorophores: what is “native” reporting?

Intrinsic biological fluorescence arises from molecular structures already embedded within cellular physiology, rather than introduced as external reporters. Among these, aromatic α-amino acids—particularly L-tryptophan (L-Trp) and L-tyrosine (L-Tyr)—constitute the primary basis of protein autofluorescence. Their side chains contain delocalized π-electron systems capable of absorbing ultraviolet radiation and emitting fluorescence, enabling label-free optical readouts that are inherently coupled to protein structure, conformation, and microenvironment (Chen, 1967; Victorovich et al., 2021).

This intrinsic fluorescence is not incidental but a direct consequence of molecular architecture. L-Trp and L-Tyr absorb predominantly in the UV-B region (≈280–315 nm), with spectral properties modulated by local polarity, hydrogen bonding, and conformational constraints. As a result, their emission encodes information about protein folding, binding interactions, and environmental heterogeneity—without requiring exogenous labeling. In this sense, endogenous fluorophores operate as minimally perturbative reporters: they do not bind, sequester, or redistribute analytes but instead reflect the thermodynamic state of the system to which they intrinsically belong (Chen, 1967; Mach et al., 1992; Parthasarathy et al., 2018; Victorovich et al., 2021).

Beyond proteinogenic residues, the endogenous fluorescence landscape is expanded by metabolites derived from L-Trp through the kynurenine pathway toward NAD⁺ biosynthesis (Badawy, 2017; Savitz, 2020). These compounds—including L-kynurenine and 3-hydroxy-L-kynurenine—retain aromatic character but exhibit enhanced electron-donating capacity, leading to bathochromically shifted absorption into the UV-A region (≈315–380 nm), closer to the visible spectrum. This spectral progression—from electron-poor systems such as L-phenylalanine (L-Phe) to electron-rich kynurenine derivatives—illustrates how subtle chemical modifications within endogenous pathways tune optical properties in a predictable manner, a principle relevant to probe design (Fukunaga et al., 1982; Tomek et al., 2013).

Autofluorescence imaging most commonly exploits the redox cofactors NAD(P)H and flavins (FAD/FMN), whose reduced or oxidized states determine whether they fluoresce (Blacker and Duchen, 2016; Blacker et al., 2017). The optical redox ratio (typically derived from NADH and FAD fluorescence intensities) provides a coarse but spatially resolved metabolic readout, and FLIM extends this by separating protein-bound from free NADH states, which correlate with metabolic pathway utilization (Molnar and Miskolci, 2024; Szulczewski et al., 2024). Crucially, the addition of exogenous dyes can itself alter metabolic activity, confounding the very question under investigation—a particularly acute problem for metabolic imaging (Tu et al., 2017).

L-Trp metabolites, nicotinamides, and flavins introduce a dynamic dimension to native fluorescence. Unlike protein-bound fluorophores, their concentrations are not static but reflect metabolic flux, cellular state, and physiological context. Thus, endogenous fluorescence is not merely structural but biochemical: it reports on both molecular organization and metabolic activity simultaneously. This dual encoding highlights a central advantage of label-free approaches—signal generation is inseparable from biological function, minimizing measurement back-action.

Photoacoustic tomography (PAT) exemplifies these principles at a larger scale (Shaked et al., 2023). By exploiting the photoacoustic effect—light absorbed by endogenous molecules is converted to heat, generating acoustic waves via thermoelastic expansion—PAT achieves three-dimensional, high-resolution imaging beyond the optical diffusion limit. Combining optical absorption contrast with ultrasound detection, PAT enables multiscale structural and functional imaging in vivo without introducing exogenous labels. As illustrated in Figure 2, this modality spans from subcellular organelles to whole small-animal imaging using the same contrast mechanism.

2.2 The limits of label-free: ambiguity and the need for validation

The same biochemical richness that underlies native fluorescence also imposes fundamental limitations. Endogenous fluorophores are neither spectrally isolated nor uniquely attributable: overlapping absorption and emission profiles among aromatic amino acids, kynurenine metabolites, and redox cofactors complicate signal deconvolution and quantitative interpretation.

A key limitation is that NAD(P)H autofluorescence cannot distinguish the relative contributions of NADH versus NADPH, obstructing definitive interpretation of metabolic readouts; this ambiguity has been explicitly highlighted as a primary motivation for orthogonal biosensor validation. [6] Even when lifetimes or spectra are measured with high precision, multiple species can overlap, and any label-free claim must contend with the microenvironment dependence of fluorescence lifetimes (pH, binding partner identity, local dielectric properties), which can be either a feature—encoding sensitivity to local conditions—or a confounding factor, producing non-specificity (Shaked et al., 2023).

Moreover, L-Trp, L-Tyr, and multiple kynurenine derivatives contribute to UV-region fluorescence, with spectral features that shift as a function of environment, binding state, and local dielectric properties. This means that individual amino acid quantification may be ambiguous and not readily assignable to any specific cellular process. Metabolic contributions introduce an additional layer of complexity: kynurenine pathway activity and NAD⁺ biosynthesis are highly context-dependent, varying with inflammation, immune activation, aging, and disease. As a result, changes in fluorescence intensity or lifetime may reflect alterations in metabolite concentrations rather than the specific biological process under investigation. In this sense, label-free signals are physiologically grounded but not intrinsically specific.

This ambiguity does not negate the value of native fluorescence but reframes it: label-free imaging provides a minimally perturbative but multiplexed readout, in which multiple biochemical processes are encoded within a single optical signal. Consequently, orthogonal validation strategies—spectral unmixing, FLIM, or complementary biochemical assays—are essential to disentangle these contributions and preserve quantitative interpretability.

A pragmatic conclusion emerges: label-free imaging is not a replacement for probes but a benchmark. It defines a lower bound on perturbation and an upper bound on interpretability challenges. The goal becomes not “label-free everywhere,” but rather “probe-based specificity with label-free-like fidelity,” enforced through explicit validation and perturbation-aware experimental design (Szulczewski et al., 2024).

In Table 1, a comparative overview of the most successful imaging strategies nowadays is shown. The advantages and disadvantages of each one, their requirements and characteristics, as well as their own particular “observer effect”, will be further discussed throughout the review.

TABLE 1. Comparative overview of imaging strategies: key advantages and limitations across six experimental dimensions.

Abbreviations: NAD(P)H, nicotinamide adenine dinucleotide (phosphate); FLIM, fluorescence lifetime imaging microscopy; ISC, intersystem crossing; ΔΨ_m, mitochondrial membrane potential; ROS, reactive oxygen species; Tz–TCO, tetrazine–trans-cyclooctene; SPAAC, strain-promoted azide–alkyne cycloaddition.

2.3 Endogenous vs. exogenous fluorescence: a side-by-side analytical comparison

A rigorous comparison between label-free and probe-based imaging requires moving beyond qualitative description to identify the specific mechanisms by which each approach succeeds and fails as a measurement strategy. Four analytical axes are particularly important: signal origin, perturbation mechanism, quantitative fidelity, and experimental accessibility.

2.3.1 Signal origin

Endogenous fluorescence arises from molecules constitutively present in cellular biochemistry, NAD(P)H, flavins, aromatic amino acids, and kynurenine metabolites, whose optical properties reflect functional state rather than imposed labeling. Exogenous probes generate signal through deliberate molecular recognition, partitioning, or covalent reaction; their presence is by definition superimposed on the system. This distinction matters because it determines whether the signal is intrinsically coupled to biological function or depends on an externally introduced equilibrium that can shift independently of the biology under study.

2.3.2 Perturbation mechanism

Label-free imaging perturbs cells primarily through photon delivery, phototoxicity risk scales with excitation energy, illumination dose, and the photochemical reactivity of endogenous chromophores (see Section 5.2). Synthetic probes add perturbation through three additional channels: chemical back-action (binding competition, buffering, or pH disturbance), subcellular pharmacology (membrane depolarization, organelle function disruption), and additive photochemistry (new triplet-state and ROS-generating pathways). The perturbation budget of synthetic probes is therefore structurally larger and mechanistically more complex than that of label-free imaging, even when illumination conditions are equalized.

2.3.3 Quantitative fidelity

Neither approach is inherently quantitative. NAD(P)H autofluorescence cannot distinguish NADH from NADPH contributions, and its lifetime is sensitive to multiple environmental variables simultaneously, making absolute metabolic flux quantification difficult without orthogonal validation. Exogenous intensity-based probes are concentration-dependent and subject to partitioning artifacts; even ratiometric probes assume a two-state model that may not hold in all cellular environments. FLIM partially resolves both problems by providing concentration-independent lifetimes but introduces its own instrument-dependent artifacts (see Section 7.2). Neither approach provides ground-truth quantification in isolation; both require orthogonal validation for absolute interpretations.

2.3.4 Experimental accessibility

Label-free imaging requires no probe synthesis or loading, but demands technically sophisticated instrumentation (multiphoton excitation, time-resolved detection) and generates signals that are often weak relative to background and spectrally congested. Exogenous probes provide higher signal-to-noise ratios with simpler optical setups but require careful optimization of loading concentration, incubation time, and washing protocol, all of which introduce additional experimental variables. In practice, most biological imaging laboratories use probe-based approaches for routine experiments and resort to autofluorescence measurements for specific metabolic questions, a pragmatic division that reflects the complementary strengths of each strategy rather than a clear superiority of either.

3 The buffering dilemma: when sensors reshape signaling kinetics

Of all the forms of probe back-action discussed in this review, Ca²⁺ buffering by synthetic indicators is perhaps the most instructive, not because it is the most toxic, but because it is the most mathematically transparent. A high-affinity chelator introduced into the cytosol does not merely occupy a spectator role; it enters into direct thermodynamic competition with every endogenous Ca²⁺-binding protein for the same pool of free ions (Tsien, 1989; Neher, 1995). The consequences are not subtle: buffering capacity, diffusion gradients, and receptor feedback loops are all reshaped in proportion to the indicator’s concentration and its on-rate relative to endogenous buffers (Dargan and Parker, 2003).What makes this case paradigmatic is that the perturbation is not an accident of poor probe design, it is an inescapable consequence of the detection principle itself. To sense Ca²⁺ with sufficient signal-to-noise, the indicator must bind Ca²⁺; to bind Ca²⁺ competitively, it must buffer it. There is no regime in which a high-affinity chelator reports Ca²⁺ without also reshaping the Ca²⁺ landscape it reports on. This section examines how that fundamental tension manifests at the level of signal kinetics, spatial patterning, and receptor-level feedback, and why it demands that Ca²⁺ imaging data be interpreted not as a readout of free Ca²⁺, but as a readout of free Ca²⁺ in the presence of an additional, experimentally introduced buffer. In Figure 3, the buffering effect of Ca(II) ion sensors is represented.

3.1 Ca²⁺ sensing as a canonical back-action problem

Few areas illustrate probe back-action as clearly as intracellular Ca²⁺ imaging. Classical Ca²⁺ indicators—quin-2, fura-2, indo-1—are derivatives of high-affinity chelator chemistry that can be introduced into cells at high concentrations, sometimes reaching millimolar intracellular levels. In his foundational Methods in Cell Biology chapter, Tsien established that such loading can substantially buffer cytosolic [Ca²⁺] and may itself be used to estimate fluxes and buffering capacity—underscoring that these indicators are not passive reporters (Tsien, 1989). The same source highlights practical complications arising from compartmentalization and active extrusion of dyes by transporters, meaning that even before biological interpretation is considered, the probe distribution may diverge substantially from the intended localization (Tsien, 1989; McMahon and Jackson, 2018).

This reveals a fundamental conflict between measurement sensitivity and mechanistic fidelity: to detect Ca²⁺ with sufficient signal-to-noise ratio, one typically increases probe concentration, but doing so necessarily increases the buffering capacity of the cytosol and alters the kinetics and spatial propagation of the very signal being measured. The indicator thus becomes both the ruler and a force applied to the object being measured.

3.2 Competition with endogenous binding proteins: altering IP₃-evoked patterns

Dargan and Parker directly demonstrated that buffer kinetics—not merely affinity—reshape IP₃-evoked Ca²⁺ signals in Xenopus oocytes. The slow buffer EGTA accelerated Ca²⁺ signals and “balkanized” propagating waves into localized puff-like events, whereas the fast buffer BAPTA slowed responses and promoted spatially uniform (“globalized”) Ca²⁺ signals. [9] Crucially, these differential effects were attributed to Ca²⁺ feedback within and between IP₃ receptor clusters: EGTA’s slow on-rate was insufficient to influence short-range feedback within puff sites but could intercept Ca²⁺ diffusing between clusters, while BAPTA’s fast on-rate disrupted local feedback and could act as a “shuttle buffer,” potentially enhancing coupling across longer ranges (Dargan and Parker, 2003).

The authors also demonstrated that Ca²⁺ signals evoked by influx through voltage-gated channels were substantially less affected by EGTA or BAPTA than IP₃R-mediated release, providing mechanistic specificity: probe back-action was exerted primarily through modulation of Ca²⁺-induced Ca²⁺ release (CICR) feedback, not through generic Ca²⁺ clearance (Dargan and Parker, 2003). This finding has a profound implication: the probe does not merely observe Ca²⁺; it actively participates in the decision-making machinery of Ca²⁺ signaling by determining whether local feedback loops are dominated by facilitation or by buffering. Spatial microdomains that encode biological decisions—local vs. global Ca²⁺ responses, puff vs. wave initiation—can be reclassified by the presence of the indicator itself.

3.3 Kinetics and microenvironment: when “sensor response” is not analyte response

Tsien further highlighted that Ca²⁺-binding kinetics of indicators can appear substantially slower in the cytoplasm than in aqueous solution, implying that the recorded “response time” is an environment-dependent convolution of dye and biology (Tsien, 1989). This matters because if the indicator responds more slowly than the biological transient, the recorded waveform reflects a convolution of physiology and probe kinetics. When the dye is also a buffer, this convolution becomes self-referential: dye kinetics reshape the transient that the dye then reports (McMahon and Jackson, 2018).

Mitigation strategies exist—lower-affinity indicators, minimal loading protocols, careful calibration, and cross-method comparisons—but the key conceptual insight remains: high-affinity chelators intrinsically compete with endogenous Ca²⁺-binding proteins and alter the kinetics and spatial propagation of the signals they are intended to characterize. This makes the Ca²⁺ indicator paradigm a near-perfect model system for studying probe back-action in quantitative cell biology.

4 Metabolic and subcellular interference: organelle accumulation, pH, and “dark toxicity”

The targeting of subcellular organelles by fluorescent probes is routinely framed as a problem of chemical specificity, how selectively does the probe reach its intended compartment? But this framing misses a more fundamental issue: the same physicochemical properties that drive organelle accumulation are, in most cases, pharmacologically active in their own right (Lin et al., 2021; 2022; Sokolov et al., 2023). Lipophilic cations accumulate in mitochondria because the large negative inner membrane potential pulls them in; but at the concentrations required for reliable imaging, those same cations dissipate the gradient that attracted them, impair electron transport, and stimulate uncoupled respiration. Weak-base amines accumulate in lysosomes because acidic compartments protonate and trap them; but in doing so, they titrate the very proton gradient that defines lysosomal identity (Lin et al., 2021; 2022; Cabello et al., 2024). In both cases, probe localization and probe toxicity are not independent variables, they are two expressions of the same underlying chemistry, and the experimental conditions that maximize the former tend to exacerbate the latter. The concept of “dark toxicity” extends this argument further still: organelle-targeted probes can disrupt mitochondrial bioenergetics and lysosomal function entirely in the absence of light, meaning that their biological footprint precedes any imaging session and cannot be attributed to photoexcitation (Sokolov et al., 2023). This section argues that organelle-targeted dyes should be understood not as inert molecular labels that happen to concentrate in specific compartments, but as subcellular pharmacological agents whose imaging utility and biological interference are inseparable by design.

4.1 Mitochondria: ΔΨ_m-driven targeting as both mechanism and vulnerability

Mitochondrial targeting in fluorescence imaging frequently exploits the large, negative inner membrane potential (ΔΨ_m), which drives the electrophoretic accumulation of cationic dyes such as rhodamines, TPP (triphenylphosphonium) conjugates, and TMRE/TMRM-like motifs (Lin et al., 2021). This strategy is chemically elegant and operationally straightforward, but it embeds two distinct perturbation pathways.

First, it creates a positive feedback loop: accumulation depends on ΔΨ_m, but sufficiently high local concentrations of lipophilic cations can depolarize the inner membrane or disrupt electron transport chain (ETC.) function. Lin et al. explicitly note that at elevated concentrations, cationic targeting groups can depolarize mitochondrial membrane potential or impair, ETC., complexes (Lin et al., 2021). Second, it makes probe localization contingent on the very physiology under study: if ΔΨ_m collapses—whether as part of a biological event (e.g., apoptotic onset) or as a consequence of probe toxicity—localization and retention fail simultaneously, creating serious misinterpretation risks where a biological change and a probe artifact become indistinguishable (Lin et al., 2022).

A critical imaging corollary is that “mitochondrial dyes” are not purely mitochondrial reporters: Nicholls emphasizes that cationic probes such as TMRM and rhodamine 123 are influenced by both the mitochondrial membrane potential and the plasma membrane potential, complicating mechanistic interpretation and making absolute quantification intractable in intact cells (Nicholls, 2011). Even absent overt toxicity, potential-sensing dyes thus import confounds by coupling two distinct electrical compartments into a single fluorescent readout. Approaches that normalize for plasma membrane potential changes—or use ratiometric indicators—partially address this issue but add experimental complexity.

4.2 Lysosomes: lysosomotropism as a perturbation engine

Lysosomal targeting in fluorescent probes typically relies on lipophilic amine motifs (morpholine, dimethylamine) that diffuse freely across membranes and become protonated—and thereby trapped—within acidic compartments. Lin et al. report that accumulation can reach several hundred-fold relative to the cytosol, providing excellent signal-to-background ratios (Lin et al., 2021). However, this same mechanism is intrinsically perturbative: lysosomotropic amines can raise intralysosomal pH, alter organelle morphology and enzymatic activity, and may cause cell death under conditions of prolonged imaging—rendering such probes unsuitable for longitudinal experiments (Lin et al., 2021). Moreover, pH-based trapping is not strictly specific: probes can label endosomes as well as mature lysosomes, depending on pK_a and compartment acidity, and may fail to report on less-acidic lysosomal subpopulations (Lin et al., 2021).

The mechanistic tension here is fundamental: the more strongly a probe is trapped in acidic compartments (higher SNR, better localization), the more potently it acts as an alkalinizing agent—sequestering protons and thereby altering the very acid-base chemistry that drives its own accumulation. Probe strength and probe toxicity are not independent variables; they are opposing faces of the same physicochemical property. This consideration argues for pK _a-tuned probes that report lysosomal pH without substantially buffering it, an active area of probe design.

4.3 Dark toxicity of penetrating cations: mitochondria as a sink for unintended pharmacology

The term “dark toxicity” captures a critical experimental reality: dyes can exert biological harm even in the complete absence of illumination. A mechanistically rich example involves penetrating (lipophilic) cations used as mitochondrial delivery vectors. Sokolov et al. provide a comprehensive mechanistic summary: such cations can facilitate proton transport across inner membranes, react directly with respiratory-chain redox centers, disrupt membrane structural integrity, and inhibit metabolic enzymes; because they accumulate in mitochondria, their toxicity is characteristically mitochondrial (Sokolov et al., 2023). More specifically, alkylated TPP derivatives can transiently depolarize ΔΨ_m as they cross the inner membrane, stimulating coupled respiration and enhancing the protonophoric activity of free fatty acids; at higher concentrations, they inhibit respiration, plausibly through direct inhibition of, ETC., complexes or through detergent-like disruption of the inner membrane bilayer (Sokolov et al., 2023).

This implies that a mitochondrial targeting group is not merely a postal code directing fluorophore delivery; it is itself a bioenergetic effector. Consequently, “mitochondria-localized fluorescence” may in part be a marker of where a xenobiotic cation is acting pharmacologically, not purely where it is reporting on endogenous physiology. Concentration regimes that appear non-toxic by conventional cytotoxicity assays (cell viability, membrane integrity) may nonetheless exert subcellular metabolic effects that compound over extended imaging sessions.

This raises a question that deserves explicit framing: at what point does an imaging agent become a pharmacological effector? The distinction is not merely semantic; it determines whether a fluorescence readout reports on an unperturbed biological state or on the response of a cell to a xenobiotic intervention. We propose that the operational boundary should be defined empirically, at the level of specific biological endpoints, rather than by chemical structure alone. A probe may be considered to act primarily as an imaging agent when: (i) organelle morphology, as assessed by orthogonal label-free methods, is indistinguishable from vehicle controls; (ii) key functional parameters, ΔΨ_m for mitochondria, cathepsin activity for lysosomes, Ca²⁺ transient amplitude and kinetics for cytosolic indicators, fall within the biological variance of unlabeled cells; and (iii) cell viability and proliferation rates are unaffected at the imaging concentration over the full duration of the experiment, including in the absence of illumination. When any of these endpoints deviates significantly from control, the probe has crossed from reporter to effector, and the resulting imaging data must be interpreted within that pharmacological context. In practice, this boundary is concentration- and time-dependent: a probe that functions as a reporter at 100 nM for 30 min may act as a potent effector at 1 µM over 24 h. The implication for experimental design is that concentration-response characterization of biological endpoints — not merely cytotoxicity assays, should be a prerequisite for quantitative imaging studies, establishing the concentration window within which the imaging-agent interpretation is defensible.

5 Phototoxicity and ROS generation: bright images, oxidative costs

Phototoxicity is the perturbation that most researchers acknowledge in principle and most consistently underestimate in practice. It is typically treated as a dosimetry problem, reduce illumination intensity, limit exposure time, use longer wavelengths, as though the underlying photochemistry were benign and only its magnitude required management (Tosheva et al., 2020). This framing is inadequate. Phototoxicity is not a side effect of fluorescence excitation; it is a mechanistically predictable consequence of excited-state chemistry operating in an oxygen-rich, redox-buffered biological environment. Every fluorophore that undergoes intersystem crossing to a triplet state is, transiently, a photosensitizer; every triplet state that encounters molecular oxygen is a potential source of singlet oxygen and downstream ROS (Kähärä et al., 2022). The biological cost of this chemistry is not uniform, it depends on where in the cell the probe is localized, how efficiently its triplet state is quenched by the local environment, and how robustly the cell can detoxify the resulting oxidative load. A probe concentrated at the inner mitochondrial membrane or within lysosomal membranes generates ROS precisely where cellular redox buffering capacity is most consequential and where oxidative damage is most difficult to repair. Crucially, this section also challenges the implicit assumption that label-free autofluorescence imaging is photochemically neutral: endogenous kynurenine metabolites are bona fide photosensitizers, and the boundary between “safe” intrinsic contrast and “reactive” exogenous labeling is a matter of degree rather than kind (Shaked et al., 2023). The relevant question is therefore not whether phototoxicity occurs, but whether the probe adds photochemical pathways, and localizes them, in ways that the cell has not evolved to manage.

5.1 Phototoxicity as an emergent property of probe, light, and oxygen

Phototoxicity is commonly framed as an illumination problem, but mechanistically it is a three-body problem: fluorophore excited states, molecular oxygen, and cellular redox buffering capacity all contribute. In super-resolution microscopy—where photon fluxes are particularly high—Tosheva et al. emphasize that reactive oxygen species (ROS) are the primary mediators of phototoxicity, motivating strategies such as using red-shifted excitation wavelengths, avoiding UV, and substituting high-intensity bursts with lower-intensity, longer-exposure protocols (Tosheva et al., 2020). Importantly, they also caution that fluorescent probes used to report photodamage—such as Ca²⁺ or mitochondrial membrane potential indicators—may themselves introduce artifacts into the photodamage assessment (Tosheva et al., 2020). This creates a problematic circularity: we often use fluorescent readouts to detect phototoxicity caused by fluorescence excitation.

5.2 Triplet-state chemistry and singlet oxygen: a mechanistic lens

A mechanistic understanding of dye phototoxicity centers on ISC from the excited singlet state to the triplet state, followed by energy transfer to ground-state molecular oxygen (³O₂) to produce singlet oxygen (¹O₂) and other ROS. This process is illustrated in Figure 5. Kähärä et al. provide a rigorous mechanistic framework using BODIPY dyes: ISC to the triplet state enables reaction with ³O₂ to generate ¹O₂, leading to oxidative stress and cell death (Kähärä et al., 2022). Critically, they demonstrate a structural mitigation strategy based on intramolecular motion (IMR) in “molecular rotor” BODIPYs: IMR enables formation of an intramolecular charge-transfer (CT) state that undergoes efficient internal conversion, reducing the probability of ISC and thereby suppressing ROS generation while preserving adequate fluorescence brightness (Kähärä et al., 2022). This photophysical engineering approach—designing away from triplet formation rather than simply reducing illumination—provides a template for next-generation low-phototoxicity probes.

Photochemical reactivity in biological imaging is frequently attributed exclusively to exogenous fluorophores; however, endogenous chromophores are not photochemically inert. Several metabolites of the kynurenine pathway act as intrinsic photosensitizers, demonstrating that the capacity to generate reactive species is an inherent feature of biological chromophore chemistry (Roberts, 2001; Roberts et al., 2001).

For example, in the primate lens, kynurenines shown in Figure 1 play a dual role as UV filters and potential sources of photochemical damage. Primary metabolites such as L-kynurenine and 3-hydroxy-L-kynurenine efficiently absorb UV radiation and dissipate excitation energy predominantly through non-radiative pathways, minimizing reactive intermediate formation—a behavior that reflects an evolved photophysical balance favoring energy dissipation over reactivity in a protic polar environment. However, with aging and metabolic remodeling, the accumulation of downstream metabolites such as kynurenate and xanthurenate shifts this balance. These endogenous fluorophores exhibit photosensitizing activity consistent with Type I radical mechanisms. Generating reactive intermediates that promote protein crosslinking and aggregation, as illustrated in Figure 4. Such processes are implicated in lens opacification and cataract formation, illustrating how endogenous chromophores can transition from photoprotective UV filters to mediators of photochemical damage. In parallel, Type II pathways involving ¹O₂ intersect with L-Trp metabolism: photooxidation of this fluorophore can yield N-formyl-L-kynurenine, A photosensitizer capable of further propagating oxidative modifications. Thus, establishing a feedback loop in which photochemical reactions both generate and are amplified by endogenous chromophores (Tsentalovich et al., 2011; Avila et al., 2015; Ávila et al., 2019).

Taken together, these observations challenge a simplistic dichotomy between “safe” endogenous fluorescence and “reactive” synthetic probes. Instead, they suggest a continuum in which photochemical risk is governed by chromophore structure, local environment, and excitation conditions—a principle that should inform both label-free and probe-based experimental design.

5.3 Exogenous visible/NIR probes vs. native autofluorescence

Label-free autofluorescence imaging still requires photon delivery and can induce photodamage when energy is high (Shaked et al., 2023). Yet the “phototoxicity budget” differs fundamentally: native fluorophores are present at physiological concentrations and are embedded in evolved redox systems with dedicated repair mechanisms, whereas exogenous probes can add new triplet/ROS pathways and concentrate at membranes or organelles where ROS damage is locally amplified. The tension is therefore not simply “label-free is safe” but rather “label-free avoids adding new photochemistry and adverse partitioning.”

Despite the intrinsic photoreactivity noted above, endogenous fluorophores generally operate under photophysical regimes that favor low perturbation. Their absorption cross-sections are modest, their excitation typically occurs in the UV range with rapid non-radiative relaxation, and their cellular concentrations are tightly regulated by metabolism. In contrast, synthetic probes are deliberately engineered for high molar brightness, extended conjugation systems, and visible or near-infrared (NIR) excitation—features that enhance detectability but also increase the probability of triplet-state formation and ROS generation.

This comparison underscores a central principle: brightness and specificity in probe design are often achieved at the expense of photochemical neutrality, whereas endogenous fluorophores reflect an evolutionary compromise that prioritizes functional integration and controlled reactivity. Label-free autofluorescence therefore serves not as a perfect solution but as a benchmark—one that highlights both the advantages and the unavoidable trade-offs of probe-based imaging.

5.4 Quantitative comparison of phototoxicity risk across imaging modalities

A meaningful comparison of phototoxicity across imaging strategies requires moving from qualitative risk rankings to specific photochemical parameters. Three quantifiable metrics are most relevant: the singlet oxygen quantum yield (ΦΔ), the triplet-state quantum yield (ΦT), and the photon dose required to produce a measurable biological effect (Icha et al., 2017; Kähärä et al., 2022).

For common fluorescent dyes used in live-cell imaging, ΦΔ values span several orders of magnitude. Rhodamine B exhibits ΦΔ ≈ 0.76 in organic solvents, though this drops substantially in aqueous environments; nonetheless, membrane-partitioned rhodamines retain significant photosensitizing activity due to reduced quenching by water in hydrophobic bilayer environments. BODIPY derivatives typically show ΦΔ in the range of 0.001–0.05 for standard scaffolds, rising dramatically (>0.5) upon halogenation, the structural modification that converts imaging dyes into photodynamic therapy agents. Silicon-rhodamine (SiR) dyes, widely used in STED and live-cell nanoscopy, show low ΦΔ values (<0.01) in their cell-permeable spirolactone form, contributing to their relatively favorable phototoxicity profile for super-resolution applications. Molecular rotor BODIPYs engineered for intramolecular motion-based internal conversion show further reduction of triplet yields, with phototoxicity reductions of 3–10-fold compared to standard BODIPY scaffolds under equivalent illumination conditions, as demonstrated by Kähärä et al. using quantified cell viability assays at defined photon doses (Kähärä et al., 2022).

For autofluorescence imaging, NAD(P)H two-photon excitation at 750–800 nm delivers energy primarily to bound NADH with low ISC probability; the estimated ΦΔ for NADH is <0.001 under physiological conditions, consistent with its role as a metabolic cofactor rather than a photosensitizer. However, kynurenine pathway metabolites, particularly 3-hydroxykynurenine and kynurenate, show measurable singlet oxygen generation and protein crosslinking activity under UV-A irradiation, with rate constants for protein modification in the range of 103–105 M⁻¹s⁻¹ depending on the specific metabolite and substrate. This places endogenous photosensitization in a biologically relevant but generally lower range than exogenous cationic dyes concentrated at membranes (Parker et al., 2004).

The localization dependence of phototoxicity is quantitatively important and often underappreciated. ROS generated at the inner mitochondrial membrane, where electron transport chain complexes are concentrated, can initiate apoptotic signaling at local concentrations orders of magnitude lower than those required for equivalent effects in the cytosol, because the proximity to redox-sensitive cardiolipin and cytochrome c amplifies the biological consequence of each oxidative event. This means that a mitochondria-localized dye with moderate ΦΔ can be more biologically damaging than a cytosolic dye with higher ΦΔ, illustrating why ROS yield alone is an insufficient predictor of phototoxicity in compartmentalized systems. Concentration at specific membrane domains therefore acts as a biological amplifier of photochemical events, and probe design strategies that minimize membrane accumulation, through fluorogenicity, balanced charge, or covalent targeting, reduce phototoxicity through localization control rather than purely through photophysical engineering.

6 Localization vs. functional truth: mislocalization, hydrophobicity, and the rise of targetable probes

The assumption embedded in most fluorescence imaging experiments is that a probe reporting a signal from a given compartment is, in fact, reporting on that compartment. This assumption is more fragile than it appears. Small molecules do not navigate cells by molecular recognition alone; they distribute according to the thermodynamic landscape of charge, lipophilicity, membrane potential, and compartment pH, a landscape that is itself a dynamic property of cellular physiology rather than a fixed addressing system (Tsien, 1989; Lin et al., 2021). The result is that probe localization is not a binary property that is either achieved or not, but a probabilistic equilibrium that shifts with the very biological variables under investigation. A mitochondrial dye that reports ΔΨ_m collapse may be reporting a genuine biological event, a consequence of its own accumulation-driven depolarization, or a redistribution driven by a change in plasma membrane potential, and these possibilities are, in intensity-based imaging, largely indistinguishable (Nicholls, 2011; Komlódi et al., 2018). This problem is not solved by using brighter or more photostable probes; it is a consequence of relying on physicochemical partitioning as a localization mechanism. Chemigenetic approaches, HaloTag, SNAP-tag, and related self-labeling systems, represent a genuine conceptual advance because they replace thermodynamic partitioning with covalent, genetically encoded specificity (Lincoln et al., 2022; Martin and Rivera-Fuentes, 2024). But as this section argues, they introduce a different class of perturbation: the protein tag is not a neutral scaffold but a structured macromolecular addition that can alter the folding, trafficking, interaction surface, and stoichiometry of the target protein. The observer effect is not eliminated; it is translocated from the chemistry of the dye to the biology of the fusion.

6.1 Mislocalization as a chemical inevitability

Many small-molecule probes are intrinsically promiscuous in cellular environments because they partition according to charge, lipophilicity, and organelle electrochemical gradients rather than biomolecular recognition. Tsien explicitly identified dye compartmentalization into organelles and active extrusion by transporters as common and practically important issues for Ca²⁺ indicators (Tsien, 1989). Similarly, organelle-targeting motifs—intended to direct probes to specific compartments—can lead to inadvertent endosomal or lysosomal accumulation, or to localization patterns that depend on ΔΨ_m (Lin et al., 2021). The outcome is that “where the probe is” can be a more powerful determinant of the observed signal than “what the probe is sensing,” fundamentally compromising mechanistic interpretation.

6.2 The paradox redistributed: chemigenetic tags and bioorthogonal chemical imaging as middle-ground strategies

Self-labeling protein tags such as HaloTag and SNAP-tag offer a chemically attractive compromise: genetic specificity for localization combined with the superior photophysics of synthetic organic dyes. Fluorogenic polymethine dyes that become bright upon covalent binding to SNAP-tag provide strong turn-on responses (tens-to >100-fold fluorescence increases) and enable no-wash live-cell imaging with substantially improved specificity (Martin and Rivera-Fuentes, 2024). Photoactivatable dyes (PaX) coupled to HaloTag or SNAP-tag enable live-cell nanoscopy with one-to-one dye-to-protein stoichiometry and strong colocalization even in organelles spanning extreme pH ranges (Lincoln et al., 2022).

However, the “middle ground” is not cost-free. Gregor et al. explicitly caution that self-labeling protein tags are large fusion proteins that can influence target protein localization, activity, and molecular interactions—representing an observer effect of a different, structural kind (Gregor et al., 2024). Thus, targetability trades chemical mislocalization (the failure mode of free small molecules) for biological fusion perturbation (the failure mode of genetic constructs). The observer paradox is not resolved; it is redistributed. The ideal localization strategy remains context-dependent: for proteins where fusion affects function minimally and where organelle-specific chemistry is unreliable, chemigenetic approaches offer a net improvement; for proteins where steric or stoichiometric perturbation is critical, careful validation against untagged controls remains essential.

Bioorthogonal fluorogenic chemistry offers a conceptually distinct middle-ground strategy that partially decouples the localization problem from the fusion-protein problem. Rather than relying on a genetically encoded protein tag to capture a synthetic dye, bioorthogonal approaches exploit highly selective chemical reactions — tetrazine–trans-cyclooctene (Tz–TCO) cycloadditions, Staudinger ligations, or strain-promoted azide–alkyne cycloadditions — to covalently attach a fluorophore to a biomolecule that has been metabolically or enzymatically pre-equipped with a small chemical handle (Saxon and Bertozzi, 2000; Baskin et al., 2007; Sletten and Bertozzi, 2009; Deng et al., 2024; Zhu et al., 2025). The critical photophysical feature of this strategy is fluorogenicity: many bioorthogonal dyes are essentially non-fluorescent in solution and become brightly emissive only upon reaction with their complementary partner, so that unbound probe contributes negligible background without requiring wash steps. This turns-on-upon-reaction design principle addresses one of the most persistent sources of artifactual signal in live-cell imaging — the contribution of freely diffusing, non-specifically partitioned probe to the measured fluorescence — and does so without requiring the cell to express a large fusion protein. However, bioorthogonal chemistry introduces its own perturbation budget. The metabolic incorporation of unnatural amino acids or sugars bearing bioorthogonal handles is not biologically neutral: it competes with endogenous biosynthetic pathways, can alter protein folding or glycosylation patterns, and may trigger stress responses at the concentrations required for sufficient labeling density (Lang and Chin, 2014; Beliu et al., 2019; Kim et al., 2024).

The bioorthogonal reaction itself, while highly selective in the chemical sense, occurs in a crowded intracellular environment where off-target reactivity, however rare, accumulates over the timescales of live-cell imaging. And the fluorophore delivered by the reaction — typically a membrane-permeable, lipophilic dye optimized for brightness and photostability — retains all the photophysical liabilities discussed in Section 5. Bioorthogonal fluorogenic chemistry therefore does not escape the observer paradox; it redistributes it again, from the structural perturbation of a protein tag to the metabolic perturbation of handle incorporation and the photochemical perturbation of the delivered fluorophore. What it uniquely offers is a reduction in the concentration of unbound, non-specifically localized dye — and in a field where background signal and required probe dose are major determinants of biological interference, that reduction is not trivial (Elia, 2021).

In this same “middle ground,” it is reasonable to consider that the so-called observer paradox has been partially addressed by the development of stimulated Raman scattering microscopy (SRS). This imaging modality, based on molecular vibrational transitions arising from Raman scattering and typically implemented using synchronized near-infrared laser beams, enables chemically specific, label-free visualization of biological samples while minimizing the need for bulky exogenous probes. In this context, SRS has facilitated a shift from large fluorophores -often containing complex heteroaromatic scaffolds-toward smaller, minimally perturbative probes. These include biomolecules such as amino acids enriched with stable isotopes (e.g., ²H and ¹³C) or functionalized with bioorthogonal vibrational tags such as alkynyl groups, which can be functionalized to give rise to a color palette (Hu et al., 2018). Such modifications preserve the native biochemical behavior of the molecules, allowing them to integrate into cellular metabolism with minimal disruption of signaling pathways and, in some cases, to become incorporated into macromolecular structures (Wei et al., 2016; Min et al., 2025).

As illustrated in Figure 5, SRS microscopy has been successfully applied to both cellular and tissue imaging, enabling clear differentiation of major biomolecular classes such as proteins and lipids, as well as dynamic processes including protein turnover and de novo synthesis. These capabilities highlight its potential for monitoring cellular dynamics with reduced perturbation compared to fluorescence-based approaches (Wei et al., 2015; Gao et al., 2024).

Despite its advantages, SRS microscopy remains constrained by instrumental complexity, moderate sensitivity compared to fluorescence, spectral overlap, and limited imaging depth (Wei et al., 2015; Min et al., 2025). Consequently, while SRS significantly mitigates the observer paradox with less perturbative probes, its technical limitations indicate that the act of observation is not entirely neutral. Subtle perturbations of the biological system may still arise due to the high-intensity laser irradiation required to drive the stimulated vibrational process, which can lead to energy deposition and photothermal effects under certain conditions.

7 Quantitative integrity: ratiometric vs. FLIM as defenses against concentration artifacts

Quantitative fluorescence imaging rests on a deceptively simple premise: that the measured signal can be reliably related to the biological quantity of interest. In practice, this relationship is confounded at every level, by probe concentration heterogeneity, by optical path length variations, by local environment effects on quantum yield, and by instrument-dependent factors such as excitation intensity drift and detector nonlinearity (Datta et al., 2020). Ratiometric imaging and FLIM were both developed, in different ways, as defenses against these confounds, and both represent genuine advances over single-channel intensity measurements. But it is important to be precise about what each strategy actually corrects and what it does not. Ratiometric imaging normalizes out concentration and path length effects within the assumptions of a two-state model, but remains vulnerable to spectral bleed-through, differential photobleaching of the two channels, and the implicit assumption that the probe exists in only two interconvertible forms. FLIM is, in principle, concentration-independent, and its sensitivity to molecular environment rather than probe abundance makes it particularly powerful for metabolic imaging and FRET-based interaction studies (Molnar and Miskolci, 2024; Yakimov et al., 2024). Yet FLIM is not epistemically transparent: it replaces concentration artifacts with photon-statistics artifacts, instrument response function distortions, and pile-up effects that can systematically bias lifetime estimates in ways that closely mimic genuine biological signals (Coucke et al., 2023). The deeper point is that no quantitative imaging modality eliminates measurement uncertainty, each one relocates it, trading one class of artifact for another that may be less familiar and therefore less routinely controlled. Rigorous quantitative imaging therefore requires not only choosing the right modality but explicitly characterizing the failure modes specific to that modality under the experimental conditions in use.

7.1 The concentration-dependence artifact

Intensity-based fluorescence readouts are inherently dependent on probe concentration, optical path length, excitation intensity, and local environment. Even ratiometric intensity approaches—designed to normalize out concentration effects by comparing two emission channels—can remain vulnerable to expression-level variability and spectral bleed-through unless subjected to rigorous correction (Coucke et al., 2023). The practical consequence is that without careful controls, apparent biological heterogeneity may reflect probe distribution heterogeneity rather than genuine differences in analyte concentration.

7.2 FLIM: concentration-independence with new failure modes

FLIM is repeatedly emphasized as “usually independent of fluorophore concentration,” making it a powerful choice for quantitative imaging where probe distribution is nonuniform (Malý et al., 2024). In metabolic imaging, Molnar and Miskolci explicitly note that FLIM offers critical advantages over intensity-based measurements, including independence from fluorophore concentration, and they summarize the lifetime distinctions between free and protein-bound NADH and between free and protein-bound FAD (Molnar and Miskolci, 2024). Multispectral FLIM can further separate overlapping autofluorescence components (free and bound NAD(P)H, flavins) and provide multiple independent quantitative parameters per pixel (Yakimov et al., 2024).

Yet FLIM is not an absolute solution. Coucke et al. emphasize instrumental artifacts that can compromise quantitative accuracy: TCSPC pile-up can bias measured lifetimes toward shorter values (potentially overestimating FRET efficiency), and detector saturation can skew intensity ratios; photobleaching may not alter the intrinsic lifetime of surviving molecules but reduces the photon budget and degrades multi-exponential fit quality (Coucke et al., 2023). Therefore, FLIM replaces concentration-dependent artifacts with photon-statistics and instrument-response vulnerabilities, which are no less real but are more tractable through careful instrumental calibration and pilot experiments at different count rates.

FLIM is best viewed as a robustness upgrade rather than a truth machine: it substantially reduces sensitivity to concentration heterogeneity but demands rigorous instrument-aware controls and should be combined with appropriate reference standards and photon-budget management to ensure reliable quantification.

8 Future perspectives: is label-free the ultimate goal, or can we engineer “zero-perturbation” probes?

The trajectory of the field, if read optimistically, points toward an eventual convergence: probes that are so small, so transient in their interactions, so photophysically neutral, and so precisely targeted that the distinction between labeled and label-free imaging becomes operationally irrelevant. This convergence is worth pursuing, but the framing of “zero-perturbation” as an engineering target rather than a philosophical ideal requires scrutiny. Perturbation is not a single axis that can be minimized by improving one molecular property at a time; it is a multidimensional problem in which gains along one axis, reduced buffering capacity, lower phototoxicity, improved targeting specificity, frequently come at a cost along another (Lavis and Raines, 2008; 2014). A lower-affinity Ca²⁺ indicator buffers less but also reports less faithfully at low occupancy; a molecular rotor BODIPY suppresses triplet-state ROS but sacrifices brightness; a fluorogenic chemigenetic dye eliminates background but introduces a protein tag whose structural consequences must be independently assessed (Kähärä et al., 2022; Gregor et al., 2024). What the evidence reviewed in this article suggests is that the path toward minimally perturbative probes does not run through incremental optimization of individual properties, but through a fundamental reorientation of design philosophy, one that takes endogenous fluorophores not merely as a benchmark to be surpassed, but as a blueprint to be emulated. Native chromophores are not bright, not specifically targeted, and not easily multiplexed; but they are constitutively integrated into cellular biochemistry in ways that make their presence thermodynamically invisible. The goal of next-generation probe chemistry is not to replicate this invisibility, which may be unachievable for exogenous molecules, but to reduce the biological footprint of measurement to the point where the signal is interpretable without first correcting for the instrument.

8.1 Label-free as an asymptote, not a destination

Label-free imaging is compelling because it avoids introducing exogenous binding equilibria and xenobiotic photochemistry into living systems (Shaked et al., 2023). However, it often lacks molecular specificity and requires validation by extrinsic labels to confirm biological assignments (Szulczewski et al., 2024). This suggests that label-free is not an ultimate replacement for molecular probes but an asymptotic ideal, a reference condition that defines acceptable levels of perturbation and guides the design of better probes. Progress in the field should be measured not by the elimination of labels but by the reduction of measurement back-action toward label-free-like levels while preserving the specificity advantages of synthetic chemistry.

8.2 Engineering toward “zero-perturbation” probes: design principles

Endogenous fluorophores, aromatic amino acids, kynurenine metabolites, NAD(P)H, suggest that minimally perturbative probes should emulate, rather than override, native biochemical and photophysical behavior. In these systems, fluorescence is intrinsically linked to structure, environment, or metabolic state, and does not arise from high-affinity binding, forced sequestration, or chemically imposed localization. Signal generation therefore occurs with minimal measurement back-action. In contrast, most synthetic probes achieve sensitivity and specificity through features such as strong binding affinities, lipophilic targeting motifs or extended π-systems that inherently perturb the system, as analyzed in Sections 3–5.

The design of minimally perturbative probes requires treating the fluorophore, the targeting motif, and the reactive handle as a pharmacologically integrated unit rather than as modular, independently optimizable components. As summarized in Figure 6, six synthetic principles emerge from the mechanistic evidence reviewed here, each addressing a distinct perturbation axis.

• Tune affinity to the minimum required for signal fidelity. For ion sensors, affinity should be matched to the physiological concentration range of the target analyte, not maximized for sensitivity. Indicators with K_d values near the resting analyte concentration minimize fractional occupancy changes and therefore minimize buffering back-action. For Ca²⁺, this argues for indicators with K_d in the range of 1–10 µM for cytosolic applications rather than the sub-micromolar affinities of classical chelators. (Tsien, 1989; Dargan and Parker, 2003).
• Minimize the intrinsic biological activity of the targeting motif. Lipophilic cations and basic amines are not chemically neutral postal codes; they are bioenergetically active entities. Synthetic strategies that achieve organelle selectivity through recognition-based mechanisms, for example, cardiolipin-binding peptide mimetics for mitochondria, or pH-responsive spirolactam probes with pK _a below the lysosomal set point, decouple localization from pharmacological interference. (Lin et al., 2021; Sokolov et al., 2023).
• Engineer away from triplet-state formation. High ISC probability is not an intrinsic property of organic chromophores but a consequence of heavy-atom effects, extended conjugation, and the absence of efficient non-radiative decay pathways. Molecular rotors, twisted intramolecular charge-transfer (TICT) fluorophores, and cyclooctatetraene (COT)-conjugated dyes all suppress triplet yield through competing intramolecular motion or triplet-quenching mechanisms, providing a synthetic route to reduced phototoxicity without sacrificing spectral range. (Kähärä et al., 2022).
• Exploit fluorogenicity to lower effective probe dose. Turn-on-upon-binding or turn-on-upon-reaction designs, including spirolactam opening, excited-state intramolecular proton transfer (ESIPT), and bioorthogonal Tz–TCO cycloaddition, reduce the concentration of optically active, biologically interfering probe required to achieve adequate signal-to-noise. Lower effective concentration directly reduces buffering, membrane accumulation, and photon-budget costs. (Saxon and Bertozzi, 2000; Baskin et al., 2007; Sletten and Bertozzi, 2009; Deng et al., 2024; Zhu et al., 2025).
• Favor covalent over non-covalent localization. Non-covalent probes are subject to continuous redistribution as the biological variables that drive their accumulation, ΔΨ_m, pH, protein binding, change during the experiment. Covalent localization strategies (HaloTag, SNAP-tag, bioorthogonal ligation) fix the probe position at the moment of reaction, decoupling probe distribution from dynamic biology and providing a more stable interpretive foundation. (Lincoln et al., 2022; Martin and Rivera-Fuentes, 2024).
• Co-optimize photophysics and biological activity in the same synthetic iteration. The most significant advance in probe design practice would be to include perturbation assays, dark toxicity, organelle function, ROS yield, pH effect, as routine synthetic screening criteria alongside brightness and photostability, rather than as late-stage biological validation steps. (Shaked et al., 2023; Szulczewski et al., 2024).

Finally, native fluorescence is inherently multiplexed and context-dependent, reflecting overlapping biochemical processes rather than isolated single analytes. Future probe design may benefit from embracing this paradigm through ratiometric, lifetime-based, or environment-sensitive readouts that reduce reliance on perturbative molecular recognition mechanisms. Taken together, “zero-perturbation” probes are defined not by the absence of interaction but by their ability to report biological states while remaining as close as possible to endogenous chemical and photophysical behavior.

8.3 Future directions: toward reliable, bias-aware biological imaging

The field of biological fluorescence imaging is at an inflection point. The tools available, super-resolution nanoscopy, FLIM, bioorthogonal chemistry, chemigenetic tags, have outpaced the standards by which their outputs are validated and interpreted. Three axes of development are needed to close this gap.

8.3.1 Measurement standards and community reporting norms

A minimum reporting standard for probe-based imaging studies should include: (i) the probe concentration used and a justification of why it falls within the non-effector regime for the specific biological endpoint under study; (ii) a dark toxicity control at the imaging concentration over the full experimental duration; (iii) a phototoxicity control at the illumination dose used; and (iv) at least one orthogonal validation of the key biological claim, preferably a label-free readout, a genetically encoded sensor, or a biochemical assay. These requirements are not more stringent than is expected in pharmacological studies; they represent the application of existing rigor to a domain that has historically operated below that standard. Journals publishing cell imaging studies should move toward requiring perturbation characterization as routine supplementary data, analogous to the requirement for selectivity profiling in chemical biology papers.

8.3.2 Probe design philosophy: from optical metrics to biological invariants

The next-generation of probe evaluation should shift from primary optimization of brightness, photostability, and Stokes shift toward co-optimization of biological footprint. Specifically, this means: developing high-throughput assays for organelle function (ΔΨ_m, lysosomal pH, ER stress markers) at probe concentrations used for imaging; systematic measurement of ROS generation under imaging conditions using orthogonal ROS sensors; and incorporation of dark toxicity screening early in the synthetic development pipeline rather than as a post hoc biological test. Computational approaches, molecular dynamics simulations of membrane partitioning, QM/MM modeling of ISC rates, are increasingly tractable and could guide synthetic prioritization before cell-based screening.

8.3.3 Convergence of label-free and probe-based imaging

The most productive future direction is not the replacement of probes by label-free methods, but the systematic integration of the two within the same experimental framework. Label-free autofluorescence (FLIM of NAD(P)H and FAD) should become a routine pre- and post-imaging reference in any experiment that introduces synthetic probes, providing a functional fingerprint of cellular state before and after labeling. Discrepancies between labeled and label-free readouts are not failures, they are information, identifying the perturbation introduced by the probe and enabling its quantitative correction. In this integrated paradigm, the observer effect is not eliminated but made explicit, transparent, and ultimately correctable, transforming a fundamental limitation of biological imaging into a quantifiable experimental variable.

8.4 A practical decision framework: matching imaging strategy to biological question

The perturbation landscape described in Sections 3–6 does not argue uniformly against synthetic probes—it argues for context-aware selection. The following framework organizes probe and technique choice by biological question, with explicit attention to the perturbation risk that dominates in each case.

8.4.1 Detecting metal ions (Ca²⁺, Zn²⁺, Fe²⁺)

For Ca²⁺ signaling studies where kinetics and spatial patterns are the primary readout, use lower-affinity indicators (e.g., Fluo-4 or Cal-520 at minimal loading concentrations) combined with ratiometric detection where possible. Critically, validate transient amplitude and wave propagation against an independent perturbation-free reference, ideally a genetically encoded indicator (GCaMP), to confirm that chelator back-action is not reshaping the observed signal. Avoid fura-2 at intracellular concentrations above 50 µM. For Zn²⁺ and Fe²⁺, where buffering back-action is less established, fluorogenic turn-on probes with selectivity confirmed by metal competition assays are preferred.

8.4.2 Studying organelle identity and dynamics

For mitochondria, use TMRM at depolarizing concentrations (<50 nM in quench mode) with simultaneous plasma membrane potential monitoring, or switch to chemigenetic MitoTracker alternatives (HaloTag-targeted fluorogenic dyes) that are ΔΨ_m-independent. For lysosomes, pK _a-tuned fluorogenic probes that report pH without substantially buffering it are strongly preferred over classical lysosomotropic dyes for functional studies; LysoSensor dyes are acceptable for morphological imaging at low concentrations and short exposure times. For ER and Golgi, bioorthogonal metabolic labeling of glycans or lipids avoids organelle-targeted dye toxicity entirely.

8.4.3 Studying cell metabolism

This is the domain where label-free imaging is most clearly the first-line tool. NAD(P)H and FAD FLIM provide metabolic readouts with minimal perturbation, and multispectral FLIM can partially resolve free vs. protein-bound contributions. Exogenous probes should be introduced only when a specific metabolite or enzyme activity cannot be assigned by autofluorescence alone, and the probe own metabolic effects should be explicitly assessed. Genetically encoded biosensors (iNAP, Peredox) provide molecular specificity with less chemical perturbation than synthetic dyes for NADH/NADPH discrimination.

8.4.4 Studying protein–protein interactions and trafficking

FLIM-FRET is the quantitative method of choice, with SNAP-tag or HaloTag delivering the donor/acceptor pair with high stoichiometric control. Validate that the tag does not alter the interaction under study by comparing tagged and untagged constructs in functional assays. For trafficking studies requiring long-term imaging, photoactivatable or fluorogenic HaloTag/SNAP-tag dyes minimize cumulative phototoxicity.

8.4.5 Studying cell–cell interactions and tissue-level organization

Label-free modalities, photoacoustic imaging, second harmonic generation (SHG), coherent anti-Stokes Raman scattering (CARS), are strongly preferred for extended in vivo or ex vivo imaging where phototoxicity accumulates across many cells. When molecular specificity is required, bioorthogonal metabolic labeling of surface glycans or lipids offers the best compromise between specificity and minimal subcellular chemical perturbation.

9 Conclusions

The central argument of this review can be stated simply: in fluorescence imaging, the measurement is never separable from the intervention. This is not a technical limitation awaiting an engineering solution — it is a consequence of the physical and chemical nature of molecular sensing in living systems, and it applies with different intensities and through different mechanisms to every strategy discussed here, from high-affinity chelators to autofluorescence lifetime imaging. What varies across strategies is not whether perturbation occurs, but where it is localized, how large it is relative to the biological signal of interest, and how transparently it can be characterized and controlled. The productive response to this reality is neither to abandon synthetic probes in favor of label-free imaging — which substitutes one set of interpretive limitations for another — nor to treat perturbation as an acceptable background cost of doing fluorescence biology. It is to make perturbation assessment a first-class experimental variable: designed for, measured, reported, and used to constrain biological interpretation. The field has made remarkable progress in probe brightness, targeting precision, and photostability; the next frontier is not optical but epistemological — developing the conceptual frameworks and experimental standards that allow imaging data to be interpreted not as a picture of the cell, but as a picture of the cell as perturbed by the act of looking at it. In this sense, the observer effect is not a problem to be solved but a condition to be honestly accounted for, and the most important advance in biological imaging may not be a new fluorophore or a new microscope, but a new standard of evidence.

Small-molecule fluorescent probes have transformed biological characterization, but they also impose measurable and mechanistically predictable perturbations on the systems they report on. High-affinity chelators reshape Ca²⁺ signaling kinetics and spatial patterning; organelle-targeting motifs can perturb mitochondrial membrane potential and lysosomal pH; penetrating lipophilic cations exhibit dark toxicity via mitochondrial bioenergetic disruption; and phototoxicity emerges as a predictable consequence of triplet-state chemistry and ROS formation. Label-free autofluorescence imaging and FLIM provide a lower-perturbation benchmark but face inherent interpretability limitations, demanding orthogonal validation. Middle-ground strategies—fluorogenic chemigenetic tags, bioorthogonal labeling, ratiometric sensing, and lifetime-based quantification—do not eliminate the observer effect but can relocate and reduce it. The next generation of imaging chemistry should therefore be judged not only by the photons collected per molecule but by the biological invariants preserved per experiment.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Eden Morales-Narváez, Universidad Nacional Autónoma de México, Mexico

Reviewed by: Jiney Jose, The University of Auckland, New Zealand

Samira Husen Alamudi, University of Indonesia, Indonesia